How India’s Trade Agreements May Price Out Affordable Medicines
India’s free trade agreements are progressively undermining access to affordable medicines. The government must resist big pharma’s narrative that stronger IP protection drives investment and innovation, and instead heed health advocacy groups that say healthcare costs for the poor will balloon.
www.theindiaforum.in
